Replies to post #463775 on Anavex Life Sciences Corp (AVXL)

[Hoskuld]

Drugs are not priced based on cost-to-produce. Biogen's COGS for Avonex, which at one point was selling $2b per year, was ~10%. The crystalized formula that I gave you as an example, Ohtuvayre, is also not at all expensive to produce. Even at $30K per year, which I don't think will be the pricing for 2-73 for AD, it would still be vastly cheaper than the mabs which would cost roughly the same - but then have the added costs that come with being a parenteral.

[sab63090]

The Europeans will not allow excessive pricing which Americans apparently do....so I think with the low cost to produce the price should be much lower, but I'm not smart enough to figure out how much cheaper than the products that are now being pushed hard!

American pay high prices and other countries don't....tell me why